Experienced in Endometrial Stromal Sarcoma

Dr. Weldon E. Chafe

Gynecologic Oncology
1250 E Marshall Street, Ob/gyn, 
Richmond, VA 
Experienced in Endometrial Stromal Sarcoma
1250 E Marshall Street, Ob/gyn, 
Richmond, VA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Weldon Chafe is a Gynecologic Oncologist in Richmond, Virginia. Dr. Chafe is rated as an Experienced provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Ovarian Cancer, Cervical Cancer, Malignant Mixed Mullerian Tumor, and Sertoli-Leydig Cell Tumor.

His clinical research consists of co-authoring 3 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gynecologic Oncology
Licenses
Obstetrics & Gynecology in VA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1250 E Marshall Street, Ob/gyn, Richmond, VA 23298

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
A Phase III Randomized Controlled Clinical Trial of Carboplatin and Paclitaxel (or Gemcitabine) Alone or in Combination With Bevacizumab (NSC #704865) Followed by Bevacizumab and Secondary Cytoreductive Surgery in Platinum-Sensitive, Recurrent Ovarian, Peritoneal Primary and Fallopian Tube Cancer. NCI-Supplied Agents: Bevacizumab (NSC #704865)
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2024
Intervention Type: Other, Drug, Biological
Study Drugs: Bevacizumab, Carboplatin, Docetaxel, Gemcitabine Hydrochloride, Paclitaxel
Study Phase: Phase 3
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
A Phase III Trial of Adjuvant Chemotherapy Following Chemoradiation as Primary Treatment for Locally Advanced Cervical Cancer Compared to Chemoradiation Alone: The OUTBACK Trial
Enrollment Status: Completed
Publish Date: November 07, 2022
Intervention Type: Other, Drug, Radiation
Study Drugs: Carboplatin, Cisplatin, Paclitaxel
Study Phase: Phase 3
Phase 2 Trial of Dose Dense (Weekly) Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Recurrent Ovarian Cancer
Phase 2 Trial of Dose Dense (Weekly) Paclitaxel With Pembrolizumab (MK-3475) in Platinum Resistant Recurrent Ovarian Cancer
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drugs: Pembrolizumab, Paclitaxel
Study Phase: Phase 2
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Can Diet and Physical Activity Modulate Ovarian, Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?
Enrollment Status: Unknown
Publish Date: February 19, 2018
Intervention Type: Other, Behavioral
Study Phase: Phase 3
View 4 Less Clinical Trials

3 Total Publications

A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.
Journal: Gynecologic oncology
Published: March 28, 2017
Similar Doctors
Distinguished in Endometrial Stromal Sarcoma
Dr. Randal J. West
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Distinguished in Endometrial Stromal Sarcoma
Dr. Randal J. West
Gynecologic Oncology | Oncology | Obstetrics and Gynecology
1401 Johnston Willis Dr, Suite 1100, 
North Chesterfield, VA 
 (9.3 miles away)
804-323-5040
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Randal West is a Gynecologic Oncologist and an Oncologist in North Chesterfield, Virginia. Dr. West is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Endometrial Cancer, Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Oophorectomy, and Hysterectomy. Dr. West is currently accepting new patients.

Distinguished in Endometrial Stromal Sarcoma
Dr. Johnny Hyde
Gynecologic Oncology | Oncology
Distinguished in Endometrial Stromal Sarcoma
Dr. Johnny Hyde
Gynecologic Oncology | Oncology

Bon Secours-Richmond Community Hospital LLC

5875 Bremo Rd, Suite 712, 
Richmond, VA 
 (5.5 miles away)
804-288-8900
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Johnny Hyde is a Gynecologic Oncologist and an Oncologist in Richmond, Virginia. Dr. Hyde is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Hernia Surgery, and Oophorectomy. Dr. Hyde is currently accepting new patients.

Distinguished in Endometrial Stromal Sarcoma
Dr. Michael E. Mccollum
Gynecologic Oncology | Oncology
Distinguished in Endometrial Stromal Sarcoma
Dr. Michael E. Mccollum
Gynecologic Oncology | Oncology

Virginia Oncology Associates

1051 Loftis Blvd, Suite 100, 
Newport News, VA 
 (60.7 miles away)
757-873-9400
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Mccollum is a Gynecologic Oncologist and an Oncologist in Newport News, Virginia. Dr. Mccollum is rated as a Distinguished provider by MediFind in the treatment of Endometrial Stromal Sarcoma. His top areas of expertise are Endometrial Cancer, Ovarian Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, and Hysterectomy. Dr. Mccollum is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chafe's expertise for a condition
ConditionClose
        View All 12 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile